Vancomycin architecture dependence on the capture efficiency of antibody-modified microbeads by magnetic nanoparticles by Kell, Arnold & Simard, Benoit
Supplementary Material (ESI) for Chemical Communications 
This journal is (c) The Royal Society of Chemistry 2007 
 S1
Vancomycin Architecture Dependence on the Capture Efficiency of Antibody-
modified Microbeads by Magnetic Nanoparticles 
 
Arnold J. Kell and Benoit Simard 
 
Steacie Institute for Molecular Sciences, National Research Council of Canada, 100 
Sussex Drive, Ottawa, Ontario, Canada K1A 0R6  
 
E-mail: benoit.simard@cnrc-nrc.gc.ca 
 
Supplementary Information 
 
Experimental 
Water-soluble iron oxide nanoparticles (FexOy) were obtained from Ferrotec Corporation 
(average diameter 10 nm, EMG 304 ferrofluid, U.S.A.).  Tetraethoxysilane (TEOS) and 
3-aminopropyldiethoxymethylsilane (APDEMS) were both ordered from Gelest, Inc. 
Ammonium hydroxide (NH4-OH, 28-30 wt %), high purity 2-propanol, 
dimethylsulfoxide (DMSO), dimethylformamide (DMF) and dichloromethane were 
obtained from EMD Chemicals, Inc.  Fluorescein cadaverine, 1μm FluoSphere 
carboxylate modified microspheres (365/415) and vancomycin-BODIPY® FL conjugate 
were purchased from Molecular Probes.  Succinic anhydride, fluorescamine, N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC), 
diisopropylethylamine, N-hydroxy succinimide (NHS), 1-hydroxybenzotriazole (HOBT), 
N,N,N′,N′-tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU), 
vancomycin, MES and PBS were purchased from Aldrich and used without further 
purification. Vancomycin polyclonal to vancomycin antibody (ab19968) was purchased 
from Abcam.  Water was purified with a Millipore Q-guard 2 purification system 
(Millipore Corporation). Only purified water was used in the experiments. 
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The vancomycin derivative was purified by RP-preparative HPLC on a Waters 
Delta Prep 4000 system, equipped with a Waters 996 photodiode detector and a Zorbax 
300SB-C18 column.  Analytical RP-HPLC was performed with an Agilent 1100 series 
HPLC employing a Zorbax 300SB-C18 column (5µm) with dimensions of 4.6x150 mm.  
Transmission electron microscopy (TEM) was used to characterize the various 
FexOy@SiO2 based core-shell nanoparticles.  The TEM images were obtained using a 
Philips CM20 FEG microscope operating at 200 kV.  Samples were prepared by 
dropcasting several drops of the particle dispersion onto 200 mesh copper/Formvar Tem 
grids with a pipet. 
The fluorescence emission spectra were recorded on a Fluoromax-3 spectrometer 
(Jobin Yvon Horiba, Instruments SA) with a 450 W Xe lamp as the excitation source and 
an excitation wavelength of 365 nm and spectra-recording at 380-600 nm. 
 
Modification of the polystyrene beads with vancomycin antibody (vAB-PS) 
 Blue fluorescent (365/415) FluoSphere carboxylate modified microspheres 
(Molecular Probes) (1μm, 0.5 mL, 1.2x109microspheres) were centrifuged and 
redispersed in 1.5 mL of 30mM MES buffer at pH=6.  The microspheres were then 
mixed with 4 mg of rabbit polyclonal to vancomycin antibody (Abcam, ab19968) in 1 
mL of MES buffer for 15 minutes before 30 mg of EDC was added to the mixture.  
Following gentle vortex mixing for 2 hours, the solution was centrifuged (2000 rpm, 10 
minutes), the supernatant removed and the microspheres redispersed in fresh phosphate 
buffered saline (PBS) buffer, pH=7.5, four times.  The microspheres were finally 
dispersed in 1.5 mL of PBS buffer, resulting in a concentration of ~1.2x109 vAb-PS/mL. 
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Synthesis of core-shell silicon dioxide encapsulated iron oxide nanoparticles 
(FexOy@SiO2 ) (SNP) 
 The nanoparticles were synthesized as reported by Ma and coworkers1 and Xia 
and coworkers.2  Briefly, 0.4 mL of a commercially available ferrofluid (ferrotec 
EMD304, comprised of a mixture of Fe3O4 and Fe2O3 nanoparticles)1, 2 was diluted in 
400 mL of Millipore water.  This stock solution was then further diluted (6 mL of the 
stock solution was diluted to 42 mL) with Millipore water and the solution was sonicated 
for 30 minutes.  Following sonication, the solution of nanoparticles was transferred to a 
3-necked 500 mL flask containing 400 mL isopropanol and mechanically stirred.  
Tetraethoxysilane (0.80 mL) was added to the flask and stirred for ~1 minute.  Following 
1 minute of stirring, 6 mL of 28% ammonium hydroxide was added all at once and 
stirring was continued overnight.  Analysis of these nanoparticles by TEM shows that 
these conditions generate core-shell nanoparticles of a total diameter of 42±6 nm, 
consisting of a ~5-10 nm iron oxide core surrounded by a smooth silicon dioxide shell 
with a thickness of 15-20 nm.  There are no detectable free FexOy nanoparticles or free 
silica nanoparticles.  A TEM image of the nanoparticles is shown below in Figure S1. 
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Figure S1: A TEM image of the FexOy@SiO2 nanoparticles (SNP). 
 
 
 
 
 
Surface modification of silicon dioxide encapsulated iron oxide nanoparticles (SNP) 
Amine-modified silica encapsulated iron oxide nanoparticles (SNP-1) 
The SNPs described above were equally distributed into 10 falcon tubes 
(~45mL/tube) and to six of the tubes 0.9 mL of aminopropyldiethoxymethylsilane 
(APDEMS) was added in order to modify the surface with a functional amine group.  The 
mixture was shaken on a mechanical shaker for 18-24 hours at which time the tubes were 
centrifuged at 7000 rpm for 45 minutes in order to precipitate the nanoparticle.  The 
nanoparticles were redispersed in DMF (15 mL) and centrifuged once again at 7000 rpm 
for 30 minutes to pellet SNP-1 and separate it from free, unreacted APDEMS (process 
repeated three times).  For experiments employing SNP-1, the nanoparticles were 
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dispersed in 30mM MES buffer at pH 6 and centrifuged (7000 rpm, 35 minutes) three 
times to ensure all DMF was removed.  A TEM image of SNP-1 dropcast from MES 
buffer is shown below in Figure S2.  The number of amine groups anchored to the 
surface of the nanoparticle surface was quantified by comparing the fluorescence 
intensity from SNP-1(fluorescamine) nanoparticle with that of a calibration curve 
constructed from various concentrations of ethanolamine reacted with fluorescamine.  
Fluorescamine is a non-fluorescent substrate that reacts with primary amines to generate 
a fluorescent derivative.  The reaction scheme is outlined in Figure S3.  The experiment 
involved dispersing 1x1013 SNP-1 in 1 mL of MES buffer and adding three drops of a 
10mg/mL solution of fluorescamine in acetone to the nanoparticle solution.  The 
nanoparticle was then magnetically confined to ensure that all of the fluorescence 
response was due to SNP-1(Fluorescamine) and not free APDEMS.  This is easily 
determined as the fluorescene intensity decreases upon magnetic confinement, suggesting 
that there is very little free amine in the solution (i.e. the fluorescence intensity decreases 
>90% upon magnetic confinement of the nanoparticle).  These data coupled with the 
calibration curve suggest that there are ~2500-3000 amines on each nanoparticle.  It is 
also worth noting that SNP-1 is stable in MES buffer for at least one month with little to 
no loss of amine functionality from the surface of the nanoparticle, as evidenced by 
reaction with fluorescamine one month after preparation (Figure S3). 
 
Supplementary Material (ESI) for Chemical Communications 
This journal is (c) The Royal Society of Chemistry 2007 
 S6
 
 
Figure S2: A TEM image of the amine-modified FexOy@SiO2 nanoparticles (SNP-1). 
 
 
Figure S3: The stability and amine surface coverage of SNP-1 by as determined by 
reaction with fluorescamine. 
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Carboxylate modified silica encapsulated iron oxide nanoparticles (SNP-2) 
Carboxylate modified nanoparticles (SNP-2) are derived directly from SNP-1.  
Instead of dispersing the SNP-1 nanoparticles in MES buffer, the nanoparticles were left 
in DMF and succinic anhydride was added to the tube to make a 1% solution and vortex 
mixed for 8 hours.  The resulting nanoparticles were washed with fresh DMF several 
times to ensure all free, unreacted succinic anhydride had been removed.  The 
nanoparticles were then dispersed in 30mM MES buffer (pH=6) and centrifuged and 
redispersed in fresh MES buffer several times to ensure all DMF was removed.  The 
efficiency of the reaction was determined by adding fluorescamine (which would react 
with any remaining amine), which did not result in a fluorescence response.  This 
suggests that at least 90% of the amine groups had reacted with the succinic anhydride.  
A TEM image of the nanoparticles is shown below in Figure S4. 
 
 
 
 
Figure S4: A TEM image of the carboxylic acid-modified FexOy@SiO2 nanoparticles 
(SNP-2). 
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Modification of an amine-modified nanoparticle through the carboxylic acid moiety 
of vancomycin (SNP-3) 
The amine-modified nanoparticles (SNP-1) in 18 mL (1x1013 particles/mL) of 30 mM 
MES buffer was charged with 2 mg of vancomycin, 8 mg of 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC) and 6 mg of N-
hydroxysuccinimide (NHS) and mixed for 6 hours at room temperature.  The resulting 
vancomycin-modified nanoparticles (SNP-3) were centrifuged and redispersed in fresh 
30mM MES buffer (6 mL) 3 times to ensure all of the free, unreacted vancomycin, EDC 
and NHS were washed free of the nanoparticle.  Following these wash steps, the SNP-3 
was dispersed in 16 mL of 30 mM MES and stored in the fridge at 4ºC.  It is noteworthy 
to highlight that there is only one carboxylic acid present on the vancomycin molecule, 
hence we know the architecture of vancomycin on the nanoparticle surface.  A TEM 
image of the nanoparticles is shown below in Figure S5. 
 
 
Figure S5: A TEM image of the vancomycin-modified FexOy@SiO2 nanoparticles  
(SNP-3). 
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In order to estimate the quantitiy of vancomycin on SNP-3, a model reaction was 
carried out in which a BODIPY-modified vancomycin was reacted with SNP-1.  Under 
conditions identical to those outlined above, 0.1 mg of BODIPY-vancomycin 
(Invitrogen) and 3 mL of SNP-1 (1x1013 particles/mL) in 30 mM MES buffer was 
charged with 1.5 mg of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride 
(EDC) and 1.0 mg of N-hydroxysuccinimide (NHS) and mixed for 6 hours at room 
temperature.  The resulting nanoparticle was washed in an identical fashion to that 
described above.  The number of vancomycin molecules anchored to the nanoparticle 
surface was quantified by comparing the fluorescence intensity from the SNP-
3(BODIPY) with that of a calibration curve constructed from various concentrations of 
BODIPY-vancomycin.  These data estimate there to be 9 vancomycin molecules on SNP-
3.  It should be noted that in the model reaction, the supernatant was highly fluorescent 
following centrifugation, suggesting that there was sufficient excess reagent to 
completely react with SNP-1 (i.e. the SNP-1 was the limiting reagent).   
 
Anchoring vancomycin to the nanoparticle surface through the vancosamine amine 
moiety (SNP-4) 
The carboxylate-modified nanoparticle (SNP-2) (1x1013 particles/mL) in 8 mL of 
30 mM MES buffer was charged with 2 mg EDC and 2 mg NHS and mixed for 30 
minutes at room temperature.  The resulting N-hydroxysuccinimidyl ester-modified 
nanoparticle (SNP-2(NHS)) was centrifuged and redispersed in fresh 30mM MES buffer 
(8 mL) 3 times to ensure all unreacted EDC and NHS were washed free of SNP-2.  The 
solution was then charged with 2 mg of vancomycin and stirred for 3 hours at room 
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temperature.  The resulting vancomycin-modified nanoparticle (SNP-4) was centrifuged 
and unreacted vancomycin was washed away with 8 mL MES buffer four times and 
finally dispersed in 8 mL MES and stored in the fridge at 4ºC.  A TEM image of the 
nanoparticles is shown below in Figure S6.   
 
 
 
 
 
Figure S6: A TEM image of the vancomycin-modified FexOy@SiO2 nanoparticles  
(SNP-4). 
 
 
It is noteworthy to highlight that there are two amines on vancomycin; a primary 
nitrogen on the vancosamine sugar ring and a secondary amine on the N-methyl leucine 
residue.  Based both on an investigation by Adamczyk3, 4 and on a model reaction we 
have carried out employing similar reaction conditions to those employed in the 
preparation of the SNP-4, we confirmed that the vancomycin should be anchored to the 
surface of SNP-4 through the vancosamine nitrogen and not the N-methyl leucine 
Supplementary Material (ESI) for Chemical Communications 
This journal is (c) The Royal Society of Chemistry 2007 
 S11
residue.  The can be ascertained through the use of mass spectrometry.  Carrying out 
HPLC-MS analysis of the reaction products of the model reaction, we confirm that there 
are no peaks in the HPLC chromatogram that show a molecular ion that fragments with 
an unmodified vancosamine sugar or unmodified disaccharide, suggesting that the only 
site of modification is the vancosamine nitrogen.  This data is pictured in Figure S7. 
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with a M+=1565 and a fragment also at 1307, 
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M+ -
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the N-methyl leucine residue
 
 
Figure S7: The HPLC-MS fragmentation products of the modified vancomycin model 
reaction. 
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Fluorescein-vancomcyin 
 Vancomycin (50 mg, 3.4x10-5 mol) was dissolved in 1 mL of DMSO.  To this was 
added fluorescein cadaverine (24mg, 3.7x10-5 mol) in 1 mL DMF.  The mixture was 
stirred and HBTU (19mg, 5.0x10-5 mol) and HOBT (6.6mg, 4.9x10-5 mol) were added as 
0.25 mL solutions in DMF.  Finally, diisopropylethylamine (10μL, 5.7x10-5 mol) was 
added and the mixture was stirred overnight.  The product was precipitated with 
dichloromethane and centrifuged to isolate the orange/yellow product.  The precipitate 
was dissolved in 3mL of Millipore water and purified via preparative reverse-phase 
HPLC (5-50% water:acetonitrile with no acid or buffer over 20 minutes, Rf=14.1 
minutes).  The product was characterized by HPLC (>93% by area) and ES-MS.  The MS 
exhibited an ion of m/z=1922, consistent with a molecular ion of [C92H99Cl2N12O28S]+. 
 When this molecule had been prepared, it was used in an experiment to estimate 
the number of vancomycin molecules anchored to the surface of SNP-4.  Under 
conditions identical to those applied above for the preparation of SNP-4, the carboxylate-
modified nanoparticle (SNP-2) (1x1013 particles/mL) in 5 mL of 30 mM MES buffer was 
charged with 1.5 mg EDC and 1.5 mg NHS and mixed for 30 minutes at room 
temperature.  The resulting SNP-2(NHS) nanoparticle was centrifuged and redispersed in 
fresh 30mM MES buffer (5 mL) 3 times to ensure all unreacted EDC and NHS were 
washed free of the nanoparticle.  The solution was then charged with 2 mg of fluorescein-
vancomycin and stirred for 3 hours at room temperature.  The resulting SNP-4 
(fluorescein) was washed in an identical fashion to that described above for SNP-4.  The 
number of vancomycin molecules anchored to the nanoparticle surface was quantified by 
comparing the fluorescence intensity from the SNP-4(fluorescein) with that of a 
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calibration curve constructed from various concentrations of fluorescein-vancomycin.  
These data indicate there are 12 vancomycin molecules on each SNP-4(fluorescein) and 
hence we estimate the same number of vancomycin on SNP-4.  It should be noted that in 
the model reaction, the supernatant was highly fluorescent following centrifugation, 
suggesting that there was sufficient excess reagent to completely react with SNP-2 (i.e. 
the SNP-2 was the limiting reagent).   
 
Fluorescence experiments 
 In separate experiments, a 25μL aliquot (3x107 microspheres) of vAb-PS was 
added to 1mL (5x1012 nanoparticles) of SNP-3 and SNP-4 in MES buffered water (pH=6) 
in a cuvette.  A fluorescence emission spectrum of the sample was run immediately 
following the addition of the vAb-PS and then thirty minutes after the addition to ensure 
there is no non-specific absorption of the microspheres to the cuvette or any precipitation 
of the microsphere-nanoparticle conjugate from solution over this timescale which would 
result in a loss of fluorescence signal and could be interpreted as magnetic capture.  We 
verified that neither of these instances occurs.  A rare earth magnet was then placed at the 
side of the cuvette and the relative capture efficiencies of SNP-3 and SNP-4 were 
elucidated by monitoring how quickly the fluorescence intensity of the vAb-PS 
decreased as a result of its interaction with the superparamagnetic SNP-3 and SNP-4.  
These data are pictured in Figure 2 of the manuscript.  A typical experiment illustrating 
the differences observed in the fluorescence emission spectra prior to magnetic 
confinement (T=0 minutes) and following 10 and 15 and 30 minutes of magnetic 
confinement (T=10 (SNP-3) and T=15 and 30 minutes (SNP-4), respectively) are 
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depicted in Figure S8.  TEM images of SNP-3 and SNP-4 interacting with vAb-PS are 
shown in Figures S9 and Figure S10, respectively. 
 
Figure S8: The fluorescence emission spectra of SNP-3 and SNP-4 mixed with vAb-PS 
prior to magnetic confinement (Time=0 minutes) and following magnetic confinement 
for 10 minutes (Time=10 minutes) for SNP-3 and for 15 and 30 (Time=15 and Time=30 
minutes, respectively) for SNP-4.  The blue fluorescent FluorSphere polystyrene 
microbeads were irradiated at 365nm and the emission was monitored from 380-600nm. 
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Figure S9: A TEM image of the SNP-3-vAb-PS conjugate.   
 
 
 
 
 
Figure S10: A TEM image of the SNP-4-vAb-PS conjugate 
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As a control experiment, 25 μL aliquots of vAb-PS (3x107 particles) were added to 
amine-modified (SNP-1) and carboxylate-modified (SNP-2) nanoparticles (1mL, 
5x1012 nanoparticles) in 30mM MES buffered water to ensure that non-specific 
absorption of the SNPs was not contributing to the capture of vAb-PS.  A typical 
experiment illustrating the differences observed in the fluorescence emission spectra prior 
to magnetic confinement (T=0 minutes) and following 10 and 30 minutes of magnetic 
confinement (T=10 (SNP-1) and T=30 minutes (SNP-2), respectively) are depicted in 
Figure S11.  TEM images of SNP-1 and SNP-2 interacting with vAb-PS are shown in 
Figures S12 and Figure S13, respectively.  
 
 
 
 
 
Figure S11: The fluorescence emission spectra of vAb-PS mixed with SNP-1 and SNP-2 
prior to magnetic confinement (Time=0 minutes) and following magnetic confinement 
for 10 minutes (Time=10 minutes) for SNP-1 and for 30 minutes (Time-30 minutes) for 
SNP-2.  The blue fluorescent FluorSphere polystyrene microbeads were irradiated at 
365nm and the emission was monitored from 380-600nm. 
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Figure S12: A TEM image of the SNP-1 mixed with vAb-PS. 
 
 
 
 
 
 
 
 
 
Figure S13: A TEM image of the SNP-2 mixed with vAb-PS. 
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